超4万批文面临出清考验 中药即将告别“尚不明确〞

Core Viewpoint - The new regulation from the National Medical Products Administration (NMPA) will eliminate ambiguous safety information in traditional Chinese medicine (TCM) product labels, significantly impacting over 70% of existing TCM approvals by 2026 [1][2]. Group 1: Background and Current Situation - The regulation, referred to as the "life and death clause" for TCM, will take effect on July 1, 2026, and aims to address the lack of safety information in TCM product labels [1]. - Currently, there are approximately 57,000 approved TCM products in China, with over 40,000 labels indicating "unclear" safety information in categories such as contraindications and adverse reactions [2]. Group 2: Impact on TCM Products - The regulation is expected to reduce the number of marketable TCM products by 30%-40%, primarily affecting those with unclear clinical value and high safety risks [2]. - Existing products on the market, such as Ban Lan Gen and Lianhua Qingwen, will not be directly affected and can continue to be used by consumers [3]. Group 3: Industry Transformation - The regulation signifies a shift in the TCM industry from quantity expansion to quality prioritization, addressing issues of low clinical value and redundancy among TCM products [4]. - An estimated 20%-30% of TCM approvals may exit the market in the next 3-5 years due to the new registration requirements [4]. Group 4: Cost Implications for Companies - Companies will face increased research costs to comply with the new safety evaluation requirements, which can range from hundreds of thousands to millions of yuan per product [6]. - Despite the increased costs, experts believe that this will not lead to a significant rise in TCM prices due to market competition and the potential for cost dilution through scale production [7]. Group 5: Long-term Industry Outlook - The regulation is seen as a necessary step for the modernization of TCM, aligning with international practices for drug safety information [7]. - The NMPA has established communication mechanisms and support channels to assist companies in meeting the new requirements, particularly for urgently needed products [7].